Waseem Qasim

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

Journal: Science translational medicine

Published: August 19, 2026

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Journal: Journal of human immunity

Published: April 19, 2026

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Journal: Journal of human immunity

Published: April 19, 2026

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Journal: The New England journal of medicine

Published: December 09, 2025

Allo-defensive, multiplex base-edited, anti-CD38 CAR T cells for 'off-the-shelf' immunotherapy.

Allo-defensive, multiplex base-edited, anti-CD38 CAR T cells for 'off-the-shelf' immunotherapy.

Journal: Haematologica

Published: August 29, 2025

Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease.

Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease.

Journal: Journal of human immunity

Published: May 06, 2025

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Journal: Blood advances

Published: March 03, 2025

Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemia.

Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemia.

Journal: Leukemia

Published: January 11, 2025

Clinical development of allogeneic chimeric antigen receptor αβ-T cells.

Clinical development of allogeneic chimeric antigen receptor αβ-T cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 03, 2025

Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy.

Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy.

Journal: Leukemia

Published: November 18, 2024

New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.

New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.

Journal: The Lancet. Oncology

Published: October 07, 2024

Safety and Diagnostic Utility of Brain Biopsy and Metagenomics in Decision-Making for Patients with Inborn Errors of Immunity (IEI) and Unexplained Neurological Manifestations.

Safety and Diagnostic Utility of Brain Biopsy and Metagenomics in Decision-Making for Patients with Inborn Errors of Immunity (IEI) and Unexplained Neurological Manifestations.

Journal: Journal of clinical immunology

Published: June 24, 2024

Showing 1-12 of 99

Last Updated: 09/26/2026